Log in

NASDAQ:ARDSAridis Pharmaceuticals News Headlines

$8.40
+0.67 (+8.67 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.63
Now: $8.40
$8.50
50-Day Range
$5.29
MA: $6.97
$8.97
52-Week Range
$3.80
Now: $8.40
$12.40
Volume1,612 shs
Average Volume9,045 shs
Market Capitalization$74.93 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.01

Headlines

Aridis Pharmaceuticals (NASDAQ ARDS) News Headlines

Source:
DateHeadline
Aridis Pharmaceuticals Inc (NASDAQ:ARDS) Given Consensus Rating of "Buy" by BrokeragesAridis Pharmaceuticals Inc (NASDAQ:ARDS) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 16 at 2:16 AM
Aridis Pharmaceuticals (ARDS) Buy Rating Reaffirmed at HC WainwrightAridis Pharmaceuticals' (ARDS) Buy Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - May 15 at 5:49 PM
Aridis Pharmaceuticals (NASDAQ:ARDS) Releases  Earnings Results, Misses Expectations By $0.06 EPSAridis Pharmaceuticals (NASDAQ:ARDS) Releases Earnings Results, Misses Expectations By $0.06 EPS
www.americanbankingnews.com - May 13 at 6:16 PM
Aridis Pharmaceuticals EPS misses by $0.19Aridis Pharmaceuticals EPS misses by $0.19
seekingalpha.com - May 12 at 5:20 PM
Aridis Pharmaceuticals Announces First Quarter 2020 ResultsAridis Pharmaceuticals Announces First Quarter 2020 Results
finance.yahoo.com - May 12 at 5:20 PM
Reviewing Eyegate Pharmaceuticals (NASDAQ:EYEG) and Aridis Pharmaceuticals (NASDAQ:ARDS)Reviewing Eyegate Pharmaceuticals (NASDAQ:EYEG) and Aridis Pharmaceuticals (NASDAQ:ARDS)
www.americanbankingnews.com - May 11 at 12:42 PM
Aridis Pharmaceuticals (NASDAQ:ARDS) Now Covered by Analysts at Maxim GroupAridis Pharmaceuticals (NASDAQ:ARDS) Now Covered by Analysts at Maxim Group
www.americanbankingnews.com - May 7 at 12:04 AM
BRIEF-Aridis Pharmaceuticals Enrolls First Covid-19 Patient In Ongoing Phase 3 AR-301 Clinical TrialBRIEF-Aridis Pharmaceuticals Enrolls First Covid-19 Patient In Ongoing Phase 3 AR-301 Clinical Trial
www.reuters.com - May 5 at 6:23 PM
Aridis Pharm enrolls first COVID-19 patient in late-stage AR-301 trialAridis Pharm enrolls first COVID-19 patient in late-stage AR-301 trial
seekingalpha.com - May 4 at 7:58 AM
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)
finance.yahoo.com - May 4 at 7:58 AM
Aridis Pharmaceuticals to Participate in Maxim Group's Infectious Disease Virtual ConferenceAridis Pharmaceuticals to Participate in Maxim Group's Infectious Disease Virtual Conference
finance.yahoo.com - April 29 at 8:00 AM
Can Aridis Pharmaceuticals’ APEX Platform Be Used to Target Coronavirus? Analyst Weighs InCan Aridis Pharmaceuticals’ APEX Platform Be Used to Target Coronavirus? Analyst Weighs In
finance.yahoo.com - April 15 at 5:28 PM
Aridis Pharmaceuticals EPS beats by $0.17Aridis Pharmaceuticals EPS beats by $0.17
seekingalpha.com - April 8 at 7:33 PM
Aridis Pharmaceuticals to Postpone Investor Day Due to Coronavirus ConcernsAridis Pharmaceuticals to Postpone Investor Day Due to Coronavirus Concerns
finance.yahoo.com - March 6 at 5:59 PM
Aridis Pharmaceuticals to Present at the 32nd Annual ROTH ConferenceAridis Pharmaceuticals to Present at the 32nd Annual ROTH Conference
finance.yahoo.com - March 5 at 11:37 AM
Aridis Pharmaceuticals Provides Update on Investor Day Featuring Key Opinion Leader Panels on Cystic Fibrosis and PneumoniaAridis Pharmaceuticals Provides Update on Investor Day Featuring Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
finance.yahoo.com - March 4 at 7:49 AM
San Jose biotech incubator where Impossible Foods hatched expands at new siteSan Jose biotech incubator where Impossible Foods hatched expands at new site
finance.yahoo.com - February 28 at 2:58 PM
Aridis Pharmaceuticals to Host Investor Day Showcasing APEX™ Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and PneumoniaAridis Pharmaceuticals to Host Investor Day Showcasing APEX™ Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
finance.yahoo.com - February 18 at 7:56 AM
Aridis Pharmaceuticals Inc. Common Stock (ARDS) Dividend HistoryAridis Pharmaceuticals Inc. Common Stock (ARDS) Dividend History
www.nasdaq.com - February 12 at 6:23 PM
Aridis Pharmaceuticals Inc. Common Stock (ARDS) Revenue EPSAridis Pharmaceuticals Inc. Common Stock (ARDS) Revenue EPS
www.nasdaq.com - February 12 at 6:23 PM
Were Hopeful That Aridis Pharmaceuticals (NASDAQ:ARDS) Will Use Its Cash WiselyWe're Hopeful That Aridis Pharmaceuticals (NASDAQ:ARDS) Will Use Its Cash Wisely
finance.yahoo.com - January 17 at 8:31 AM
We're Hopeful That Aridis Pharmaceuticals (NASDAQ:ARDS) Will Use Its Cash WiselyWe're Hopeful That Aridis Pharmaceuticals (NASDAQ:ARDS) Will Use Its Cash Wisely
finance.yahoo.com - January 17 at 8:31 AM
Aridis Pharma Up Over 30% In 3 Trading Days, Awaits Phase 3 Data In Early 2020Aridis Pharma Up Over 30% In 3 Trading Days, Awaits Phase 3 Data In Early 2020
www.nasdaq.com - January 7 at 1:32 AM
New finance chief at Aridis PharmaNew finance chief at Aridis Pharma
seekingalpha.com - January 2 at 4:09 PM
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial OfficerAridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
finance.yahoo.com - January 2 at 6:45 AM
Aridis Pharma up 43% on development of new antibody platformAridis Pharma up 43% on development of new antibody platform
seekingalpha.com - December 30 at 8:18 PM
Aridis Pharmaceuticals Inc. Common Stock (ARDS) Earnings Report DateAridis Pharmaceuticals Inc. Common Stock (ARDS) Earnings Report Date
www.nasdaq.com - November 13 at 5:55 PM
Aridis Pharmaceuticals Announces Third Quarter 2019 ResultsAridis Pharmaceuticals Announces Third Quarter 2019 Results
finance.yahoo.com - November 13 at 5:55 PM
Introducing Aridis Pharmaceuticals (NASDAQ:ARDS), The Stock That Slid 52% In The Last YearIntroducing Aridis Pharmaceuticals (NASDAQ:ARDS), The Stock That Slid 52% In The Last Year
finance.yahoo.com - October 19 at 12:53 PM
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical OfficerAridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
finance.yahoo.com - October 19 at 7:53 AM
Aridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform TechnologyAridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology
finance.yahoo.com - September 30 at 8:19 AM
Aridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare ConferenceAridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 27 at 7:20 AM
Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium Citrate) Data at IDWeek™ 2019Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium Citrate) Data at IDWeek™ 2019
finance.yahoo.com - September 27 at 7:20 AM
Aridis Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019Aridis Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019
finance.yahoo.com - September 20 at 3:25 AM
Aridis Pharmaceuticals Reports Phase 2 Clinical...Aridis Pharmaceuticals Reports Phase 2 Clinical...
www.benzinga.com - September 3 at 12:51 PM
Aridis Pharmas AR-105 flunks mid-stage study; shares down 27% premarketAridis Pharma's AR-105 flunks mid-stage study; shares down 27% premarket
seekingalpha.com - September 3 at 12:51 PM
Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas AeruginosaAridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa
finance.yahoo.com - September 3 at 12:51 PM
Aridis Pharmaceuticals stock plunges after drug trial fails to meet primary endpointAridis Pharmaceuticals stock plunges after drug trial fails to meet primary endpoint
finance.yahoo.com - September 3 at 12:51 PM
Aridis Pharmaceuticals Announces Second Quarter 2019 ResultsAridis Pharmaceuticals Announces Second Quarter 2019 Results
finance.yahoo.com - August 12 at 10:23 PM
Aridis Pharma inks option deal with Indian vaccine maker for pipeline programs and MabIgX platformAridis Pharma inks option deal with Indian vaccine maker for pipeline programs and MabIgX platform
seekingalpha.com - August 1 at 3:55 PM
Do Insiders Own Lots Of Shares In Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS)?Do Insiders Own Lots Of Shares In Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS)?
finance.yahoo.com - July 31 at 6:24 PM
Aridis Pharma inks option deal with Indian vaccine maker for MabIgX platformAridis Pharma inks option deal with Indian vaccine maker for MabIgX platform
seekingalpha.com - July 30 at 11:54 AM
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform TechnologyAridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform Technology
finance.yahoo.com - July 30 at 11:54 AM
Aridis Pharmas AR-501 an Orphan drug in EuropeAridis Pharma's AR-501 an Orphan drug in Europe
seekingalpha.com - July 19 at 1:33 PM
Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501
finance.yahoo.com - July 5 at 11:24 AM
Aridis Pharmas AR-501 an Orphan Drug in U.S. for CF lung infectionAridis Pharma's AR-501 an Orphan Drug in U.S. for CF lung infection
seekingalpha.com - June 27 at 11:33 AM
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of DirectorsAridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
finance.yahoo.com - June 10 at 12:23 PM
Aridis Pharmaceuticals Announces First Quarter 2019 ResultsAridis Pharmaceuticals Announces First Quarter 2019 Results
finance.yahoo.com - May 15 at 11:32 AM
Will Aridis Pharmaceuticals Continue to Surge Higher?Will Aridis Pharmaceuticals Continue to Surge Higher?
www.nasdaq.com - April 3 at 9:08 AM
Aridis Pharmaceuticals (ARDS) Upgraded to Buy: Heres WhyAridis Pharmaceuticals (ARDS) Upgraded to Buy: Here's Why
www.nasdaq.com - April 2 at 9:12 PM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.